Trials were searched in PubMed, Embase, the Cochrane Library database, and reviews and reference lists of relevant articles. Summary estimates of weighted mean differences (WMDs) and 95% CIs were obtained by using random-effects models. Meta-regression and subgroup analyses were performed to identify the source of heterogeneity.

Results: A total of 9 trials were reviewed in the present metaanalysis. Overall, the results of the 9 trials showed that isoflavone significantly increased FMD (WMD: 1.75%; 95% CI: 0.83%, 2.67%; P = 0.0002). Meta-regression analysis indicated that the age-adjusted baseline FMD was inversely related to effect size. Subgroup analysis showed

that oral supplementation of isoflavone had no influence on FMD KU-57788 ic50 if the age-adjusted baseline FMD was Selleckchem Barasertib >5.2% (4 trials; WMD: 0.24%; 95% CI: -0.94%, 1.42%; P = 0.69). This improvement seemed to be significant when the age-adjusted baseline FMD levels were <5.2% (5 trials; WMD: 2.22%; 95% CI: 1.15%, 3.30%; P < 0.0001), although significant heterogeneity was still detected in this low-baseline-FMD subgroup.

Conclusions: Oral isoflavone supplementation does not improve endothelial function in postmenopausal

women with high baseline FMD levels but leads to significant improvement in women with low baseline FMD levels. Am J Clin Nutr 2010;91:480-6.”
“Background and Aims: Escalating costs of pharmaceuticals for cardiovascular management highlight the need to develop effective lifestyle intervention

programs to reduce reliance on these agents. The aim of this pilot study was to evaluate the efficacy of a Comprehensive Lifestyle Intervention Program (CLIP) compared with qualitative lifestyle advice (L) and Simvastatin plus qualitative lifestyle (S + L) on cardiovascular risk factors.

Methods and Results: Sixty-five overweight adults with hypercholesterolemia were randomised to either L (qualitative advice on diet, exercise), S + L (20 mg/day Simvastatin plus L) or CLIP (6500 kJ structured menu ABT-263 mouse plan: conventional and functional foods contributing <10% energy from saturated fat, >= 3 g soluble fibre, 2.4 g plant sterols, oily fish >= 2 times/week at lunch and dinner, plus exercise advice and self monitoring) for 6 weeks. LDL-cholesterol was lowered in CLIP (-0.57 +/- 0.67 mmol/L, 15%) and S + L (-1.43 +/- 0.59 mmol/L, 37%), but did not change significantly in L (-0.17 +/- 0.59, 4%) (P < 0.001 time-by-treatment interaction). Weight and waist circumference were significantly lowered by CLIP (-4.2 +/- 2.2 kg; -5.1 +/- 2.3 cm) compared to L (-1.0 +/- 1.6 kg; -2.7 +/- 3.3 cm) and L + S (-0.7 +/- 1.4 kg; -2.4 +/- 2.3 cm), (P <= 0.003 time-by-treatment interactions). B-carotene levels within treatment groups did not change over time and were not lowered by the CLIP diet compared to L (P > 0.